Clear and Single Binocular Vision in Near 3D Displays.


Journal

Optometry and vision science : official publication of the American Academy of Optometry
ISSN: 1538-9235
Titre abrégé: Optom Vis Sci
Pays: United States
ID NLM: 8904931

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 7 11 2019
medline: 7 3 2020
entrez: 6 11 2019
Statut: ppublish

Résumé

Accommodation/convergence mismatch induced by 3D displays can cause discomfort symptoms such as those induced by accommodation/convergence mismatch in clinical vergence testing. We found that the limits of clear and single vision during vergence tests are very different between 3D and clinical tests. Clinical vergences should not be used as substitutes for measures of vergences in 3D displays. The purposes of this study were to determine whether the limits of clear and single binocular vision derived from phoropter prism vergence tests match the limits measured in a 3D display and to determine whether vergence mode, smooth versus jump, affected those limits in the 3D display. We tested the phoropter prism vergence limits of clear and single vision at 40 cm in 47 binocular young adults. In separate sessions, we tested, in a 3D display, the analogous 40-cm vergence limits for smooth vergence and jump vergence. The 3D fixation target was a Maltese cross whose visual angle changed congruently with target disparity. Our mean phoropter vergence blur and break values were similar to those reported in previous studies. The mean smooth divergence limit was less in the 3D display (9.8Δ) than in the phoropter (12.8Δ). Most smooth convergence limits were much larger in the 3D display than in the phoropter, reaching the 35Δ limit of the 3D display without blur or diplopia in 24 subjects. Mean jump vergence limits were significantly smaller than smooth vergence limits in the 3D display. The limits of clear and single binocular vision derived from phoropter vergence tests were not a good approximation of the analogous limits in our 3D display.

Identifiants

pubmed: 31688693
doi: 10.1097/OPX.0000000000001439
pmc: PMC6842124
mid: NIHMS1538643
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

850-859

Subventions

Organisme : NEI NIH HHS
ID : T35 EY007149
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Vision Res. 1986;26(6):927-42
pubmed: 3750876
Vision Res. 2006 Feb;46(4):475-84
pubmed: 16198392
Ophthalmic Physiol Opt. 2011 Mar;31(2):111-22
pubmed: 21309798
Strabismus. 2010 Jun;18(2):48-57
pubmed: 20521879
J Vis. 2011 Jul 21;11(8):11
pubmed: 21778252
Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1638-42
pubmed: 2745003
Optometry. 2001 Feb;72(2):117-22
pubmed: 11243428
Appl Opt. 1997 Jul 1;36(19):4509-15
pubmed: 18259243
J Vis. 2008 Mar 28;8(3):33.1-30
pubmed: 18484839
BMC Public Health. 2012 Sep 13;12:779
pubmed: 22974235
Optom Vis Sci. 2013 Oct;90(10):1149-55
pubmed: 23974662
Ophthalmic Physiol Opt. 2008 Sep;28(5):475-91
pubmed: 18761485
Am J Optom Physiol Opt. 1978 Nov;55(11):744-50
pubmed: 752265
Ophthalmic Physiol Opt. 1992 Jul;12(3):307-18
pubmed: 1454368
Am J Optom Arch Am Acad Optom. 1968 Jul;45(7):417-54
pubmed: 4875838

Auteurs

Katherine M Hogan (KM)

Cincinnati Children's Hospital Medical Center-Ophthalmology, Cincinnati, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH